美国 · 平台与数据 · MarketBeat
Bioventus Q3 Earnings Call Highlights
Bioventus (NASDAQ:BVS) reported third-quarter revenue growth of 3% as strength in its Pain Treatments business, Ultrasonics operation and international markets was partly offset…
在 MarketBeat 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.marketbeat.com)




